FR2360309A1 - Composition anti-microbienne contenant des derives de 1-azolyl-4-hydroxy-butane - Google Patents

Composition anti-microbienne contenant des derives de 1-azolyl-4-hydroxy-butane

Info

Publication number
FR2360309A1
FR2360309A1 FR7724264A FR7724264A FR2360309A1 FR 2360309 A1 FR2360309 A1 FR 2360309A1 FR 7724264 A FR7724264 A FR 7724264A FR 7724264 A FR7724264 A FR 7724264A FR 2360309 A1 FR2360309 A1 FR 2360309A1
Authority
FR
France
Prior art keywords
azolyl
butane
hydroxy
microbial composition
composition containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7724264A
Other languages
English (en)
French (fr)
Other versions
FR2360309B1 (OSRAM
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of FR2360309A1 publication Critical patent/FR2360309A1/fr
Application granted granted Critical
Publication of FR2360309B1 publication Critical patent/FR2360309B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7724264A 1976-08-07 1977-08-05 Composition anti-microbienne contenant des derives de 1-azolyl-4-hydroxy-butane Granted FR2360309A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762635665 DE2635665A1 (de) 1976-08-07 1976-08-07 Antimikrobielle mittel

Publications (2)

Publication Number Publication Date
FR2360309A1 true FR2360309A1 (fr) 1978-03-03
FR2360309B1 FR2360309B1 (OSRAM) 1980-04-18

Family

ID=5984992

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7724264A Granted FR2360309A1 (fr) 1976-08-07 1977-08-05 Composition anti-microbienne contenant des derives de 1-azolyl-4-hydroxy-butane

Country Status (6)

Country Link
US (1) US4215131A (OSRAM)
JP (1) JPS5326329A (OSRAM)
BE (1) BE857521A (OSRAM)
DE (1) DE2635665A1 (OSRAM)
FR (1) FR2360309A1 (OSRAM)
GB (1) GB1545682A (OSRAM)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0065204A3 (en) * 1981-05-15 1984-01-04 Bayer Ag 3-substituted 1-azolyl-3-methyl-1-phenoxy-butan-2-on and ol, process for their preparation and their application as fungicides

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2811919A1 (de) * 1978-03-18 1979-09-27 Bayer Ag Acylierte 1-azolyl-2-hydroxy-butan- derivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide
DE3021551A1 (de) * 1980-06-07 1981-12-24 Bayer Ag, 5090 Leverkusen 4-substituierte 1-azolyl-1-phenoxy-3,3-dimethyl-butan-2-one und -ole, verfahren zu ihrer herstellung und ihre verwendung als fungizide
JPS5758671A (en) * 1980-09-25 1982-04-08 Ishihara Sangyo Kaisha Ltd Phenoxyalkylazole type compound and agricultural and gardening fungicide comprising it
WO2003009815A2 (en) 2001-07-25 2003-02-06 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
US20040191315A1 (en) * 2003-03-24 2004-09-30 Mike Slattery Office products containing antimicrobial agent
CN101287411B (zh) 2005-04-28 2013-03-06 普罗秋斯生物医学公司 药物信息系统及其用途
JP2010503710A (ja) 2006-09-18 2010-02-04 ラプトール ファーマシューティカル インコーポレイテッド 受容体関連タンパク質（ｒａｐ）結合体の投与による肝障害の処置
US20110305751A1 (en) 2009-02-20 2011-12-15 To-Bbb Holding B.V. Glutathione-based drug delivery system
KR20180114970A (ko) 2009-05-06 2018-10-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2275205A1 (fr) * 1974-06-20 1976-01-16 Bayer Ag 1-imidazolyl-(1)-1-(4'-(4''-chlorophenyl)-phenoxy)-3,3-dimethylbutane-2-one et ses sels, leur preparation et medicament les contenant

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2041771C3 (de) * 1970-08-22 1979-07-26 Bayer Ag, 5090 Leverkusen derivate
DE2105490C3 (de) * 1971-02-05 1979-06-13 Bayer Ag, 5090 Leverkusen 1 -Imidazolylketonderivate
US4038404A (en) * 1972-09-26 1977-07-26 Bayer Aktiengesellschaft 1,2,4-triazole antimycotic compositions and use thereof
DE2324010C3 (de) * 1973-05-12 1981-10-08 Bayer Ag, 5090 Leverkusen 1-Substituierte 2-Triazolyl-2-phenoxyäthanol-Verbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung zur Bekämpfung von Pilzen
DE2423987C2 (de) * 1974-05-17 1986-01-16 Bayer Ag, 5090 Leverkusen Metallkomplexe von Azolyläthern, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Fungizide
DE2635666A1 (de) * 1976-08-07 1978-02-09 Bayer Ag 1-azolyl-4-hydroxy-butan-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide und bakterizide

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2275205A1 (fr) * 1974-06-20 1976-01-16 Bayer Ag 1-imidazolyl-(1)-1-(4'-(4''-chlorophenyl)-phenoxy)-3,3-dimethylbutane-2-one et ses sels, leur preparation et medicament les contenant

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0065204A3 (en) * 1981-05-15 1984-01-04 Bayer Ag 3-substituted 1-azolyl-3-methyl-1-phenoxy-butan-2-on and ol, process for their preparation and their application as fungicides
US4629732A (en) * 1981-05-15 1986-12-16 Bayer Aktiengesellschaft Fungicidally active 3-substituted 1-azolyl-3-methyl-1-phenoxy-butan-2-ones and -ols

Also Published As

Publication number Publication date
JPS5326329A (en) 1978-03-11
DE2635665A1 (de) 1978-02-09
GB1545682A (en) 1979-05-10
BE857521A (fr) 1978-02-06
FR2360309B1 (OSRAM) 1980-04-18
US4215131A (en) 1980-07-29

Similar Documents

Publication Publication Date Title
FR2360309A1 (fr) Composition anti-microbienne contenant des derives de 1-azolyl-4-hydroxy-butane
FI955124A0 (fi) Protonipumppuinhibiittorin sisältävä eläinlääkeseos
DE69637985D1 (de) Protonenpumpeninhibitoren enthaltendes arzneimittel
ES8105292A1 (es) Procedimiento para la obtencion de derivado de la difenilu- rea halogenosustituidos
ES472838A1 (es) Procedimientos para la obtencion de derivados de 3,4,5-tri- hidropiperidina.
IS3156A7 (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
ES464354A1 (es) Procedimiento de preparacion de un complejo insectifugo e insecticida estable.
Ceschel et al. In vitro permeation through porcine buccal mucosa of caffeic acid phenetyl ester (CAPE) from a topical mucoadhesive gel containing propolis
GB1533358A (en) Deamino derivatives of the kallikrein-trypsin inhibitor processes for their preparation and their use as medicament
FR2390161A1 (fr) Compositions antimicrobiennes contenant des derives d'ethers d'azolyle
FR2457689A1 (fr) Medicament hypolipemique a base de carnitine
ES478967A1 (es) Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7.
SE8002322L (sv) Medel for behandling av inflammatoriska tarmsjukdomar
FR2756561B1 (fr) Composes heteroaryles, compositions pharmaceutiques et cosmetiques les contenant et utilisations
FR2358893A1 (fr) Composition antimicrobienne contenant des 1-imidazolyl-butane-2-ones ou -butane-2-ols halogenes
FR2368959A1 (fr) Compositions contenant des derives de l'acide guanidinoalcanoique, utilisables comme medicament
US7790771B1 (en) Use of tosylchloramide(s) for treating disease of the skin, mucous membrane, organs and tissues
KR890016971A (ko) 약물 및 알코올성 중독의 예방제와 그 치료제
AU530678B2 (en) Phosphono-hydroxy-acetic acid
US3070497A (en) Method of alleviating topical fungal infections
JPS6315245B2 (OSRAM)
Morris Dermatoses from phenylmercuric salts
DE2725765C2 (OSRAM)
FR2454761A1 (fr) Composition fongicide synergique, procede de lutte contre les maladies des plantes dues aux champignons utilisant cette composition et composition pharmaceutique contenant l'ingredient actif de cette composition
Berger et al. Anthelmintic efficacy, safety, and residue evaluation of levamisole gel formulation in cattle

Legal Events

Date Code Title Description
ST Notification of lapse